9 ASX 200 shares attracting 'strong buy' ratings from the experts

There is a consensus 'strong buy rating' on these stocks from analysts on the CommSec trading platform.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares rose 2.35% in July and finished the month at 8,742.8 points on Thursday.

The benchmark index closed 0.92% lower yesterday at 8,662 points.

In July, the experts upgraded these nine ASX 200 shares to strong buy ratings.

Let's check them out.

A team of people giving the thumbs up sign.

Image source: Getty Images

9 ASX 200 shares with strong buy ratings

The following ASX 200 shares received an upgraded 'strong buy' consensus rating on the CommSec platform in July.

Telix Pharmaceuticals Ltd (ASX: TLX)

The consensus rating on Telix Pharmaceuticals shares was upgraded to a strong buy on 31 July.

The Telix share price finished the session on Friday at $20.15, down 4.28%.

Bell Potter has a buy rating on this ASX 200 tech share with a 12-month price target of $34.

Worley Ltd (ASX: WOR)

Commsec analysts reached a consensus 'strong buy' rating on Worley shares on 31 July.

The Worley share price closed at $13.38, up 0.22% yesterday.

CSL Ltd (ASX: CSL)

The consensus rating on CSL shares was upgraded to a strong buy on 22 July.

The CSL share price finished last week at $264.05, down 2.53%.

Bell Potter has a buy rating on the ASX 200 healthcare share with a 12-month price target of $305. 

Orica Ltd (ASX: ORI)

Commsec analysts reached a consensus 'strong buy' rating on Orica shares on 22 July.

The Orica share price finished the session on Friday at $21.30, down 0.37%.

UBS has a buy rating on the explosives manufacturer with a 12-month share price target of $32. 

WiseTech Global Ltd (ASX: WTC)

The consensus rating on WiseTech Global shares was upgraded to a strong buy on 22 July.

The WiseTech Global share price finished the session on Friday at $116.34, down 3.04%.

Bell Potter has a buy rating on the ASX 200 tech share and a 12-month target price of $135.

Air New Zealand Ltd (ASX: AIZ)

Commsec analysts reached a consensus 'strong buy' rating on Air New Zealand shares on 31 July.

The ASX 200 airline share closed at $116.34 on Friday, down 2.55%.

But wait, there's more!

Capstone Copper Corp (ASX: CSC)

The consensus rating on Capstone Copper shares was upgraded to a strong buy on 22 July.

Capstone Copper shares led the market on Friday after the miner reported record production.

The ASX 200 copper stock was the fastest riser of the day, up 9.46% to $9.37.

Macquarie has an outperform rating on the ASX 200 copper share with a price target of $13.30. 

Zip Co Ltd (ASX: ZIP)

Commsec analysts reached a consensus 'strong buy' rating on this ASX 200 buy now, pay later stock on 22 July.

The Zip share price finished the week at $3.25, up 0.62%.

Blackwattle portfolio managers Robert Hawkesford and Daniel Broeren said Zip shares still have 'meaningful upside'.

They commented:

We still see meaningful upside through the ongoing penetration of BNPL products in the US which has a significant runway, sitting at only ~2% today, vs ~15% and ~20% in Australia and Europe respectively.

Westgold Resources Ltd (ASX: WGX)

The consensus rating on Westgold Resources shares was upgraded to a strong buy on 22 July.

The Westgold Resources share price closed at $2.53, down 1.17%, yesterday.

Macquarie has an outperform rating on the ASX 200 gold share with a 12-month share price target of $3.60. 

Motley Fool contributor Bronwyn Allen has positions in CSL and Zip Co. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, Telix Pharmaceuticals, WiseTech Global, and Zip Co. The Motley Fool Australia has positions in and has recommended Macquarie Group and WiseTech Global. The Motley Fool Australia has recommended CSL and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Buy and sell on yellow paper with pins on them and several share price lines.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading analyst forecasts growing headwinds for Westpac and CBA shares.

Read more »

a group of people sit around a computer in an office environment.
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Do experts rate BHP, Cochlear, and ResMed shares as buys, holds, or sells?

Looking at buying these big names? Here's what experts are saying about them.

Read more »

A group of business people sit dejectedly around a table, each expressing desolation, sadness, and disappointment by holding their head in their hands, casting their gazes down and looking very glum.
Broker Notes

Guess which ASX 200 tech stock just got hit with a broker downgrade

Bell Potter has changed its rating on this popular stock.

Read more »

A girl in a red t-shirt stands against a red door blowing bubbles through a red bubble blower.
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, Westpac shares

Experts explain their ratings on these 3 ASX 200 shares.

Read more »

A woman is excited as she reads the latest rumour on her phone.
Broker Notes

3 oversold ASX shares to target right now for 70% gains

These three shares could be winners in the back half of 2026.

Read more »

A happy person clenching fists in celebration sitting at computer.
Broker Notes

Morgans rates these ASX shares as buys with up to 55% upside

The broker has good things to say about these shares.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Buy, hold, sell: Woodside, Rio Tinto, NAB shares

We review three fresh buy, hold, and sell calls from expert market analysts. 

Read more »